Eliem Therapeutics, Inc. (ELYM) - Forvard P/S multiplikatori
Keltirilgan savdo daromadiga nisbatan narx koeffitsiyenti Eliem Therapeutics (ELYM) kompaniyasining surunkli og'riqlarni davolash segmentidagi narx belgilash imkoniyatlarini namoyish etadi, bunda belgisi aktivning joriy bahosini aks ettiradi. Biznes hozirda sotib olingan immun dori ishlab chiqish tizimini integratsiya qilmoqda, bu esa vaqtincha tashqi tranzaksiyalarni cheklaydi. Yakuniy maqsad muvaffaqiyatli klinik sinovlar va bozor nishalarini egallash orqali neyrofarmatsevtika sohasidagi mavjudligini keng miqyosda kengaytirishdir.
Eliem Therapeutics Inc. (ELYM) moliyaviy va bozor koʻrsatkichlari kesimi
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Eliem Therapeutics|ELYM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Eliem Therapeutics|Tezkor likvidlik koeffitsiyenti eliemtx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ELYM - Sof moliyaviy natija|Prognoz qilingan kelajakdagi foyda Eliem Therapeutics|ELYM - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati eliemtx.com|ELYM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori Eliem Therapeutics Inc.|ELYM - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Eliem Therapeutics|ELYM - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi eliemtx.com|ELYM - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Eliem Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning dastlabki tahlili:Eliem Therapeutics (ELYM)
Eliem Therapeutics (ELYM) moliyaviy hisobotlaridagi fundamental mezonlarni aniqlash uchun bozor qiymatini prognoz qilingan daromadlar bilan nisbatda baholash juda muhimdir. Ushbu kutilayotgan narx-savdo koeffitsienti kelajakdagi savdolarning premium qismini o'lchaydi, bu esa investorlarga grafik tahlil yordamida spekulyativ vasvasani qat'iy muvofiqlik protokollari ostida rahbariyat tomonidan amalga oshirilgan CNS biotexnologiya loyihalarining haqiqiy kapitalizatsiyasidan ajratish imkonini beradi.
Eliem Therapeutics raqobatchilari
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati cyclerion.com CYCN|Forvard P/S multiplikatori PTIX|KTTA - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|BCLI - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati caratherapeutics.com|CHRO: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
